openPR Logo
Press release

Global Natural Killer (NK) Cell Therapeutics Market Analysis and Forecast, 2019-2028 - In-depth Market Report by RationalStat

09-16-2022 04:10 PM CET | Health & Medicine

Press release from: RationalStat LLC

Global Natural Killer (NK) Cell Therapeutics Market

Global Natural Killer (NK) Cell Therapeutics Market

The report titled "NK Cell Therapeutics" assesses the global market based on application, end user, and region. A comprehensive report provides a detailed historical and future market size with trend analysis. The report underlines the market share analysis, production capacities by leading players, competition overview, strategic imperatives, annual sales figures, growth avenues, clinical trial phases, drug development analysis, production overview, and competition assessment for the target players assessed in the global NK cell therapeutics market study.

Market Overview and Dynamics: Ongoing pre-clinical and clinical development of NK cell-based therapies are propelling the market growth

The global NK cell therapeutics market is expected to grow at a robust CAGR of over 50% during the forecast period of 2022-2028. NK cells have shown promising results in various molecular and combinational therapies which have increased their adoption for treatments. Also, healthcare researchers and scientists are using NK cells as an effective tool against infectious diseases and as an anti-cancer alternative to T cells. This has pushed the clinical development of NK cell-based therapies which is acting as a pivotal growth factor for the global market.
The increasing prevalence of cancer across the globe has surged the need for the development of novel therapies for its treatment. In tumor immune surveillance, NK cells play a pivotal role which further bolsters adoption of the NK cell-based therapies globally. The growing adoption of NK cell-based therapies for the treatment of cancer and other infectious diseases is augmenting market growth. Moreover, rising awareness regarding immunotherapies among the patient population is further expected to propel market growth.

North America and Europe, collectively, are expected to generate significant revenue on the back of increased R&D efforts in the development of novel therapies for cancer treatment by the leading market players present in these regions. Players operating in the market ecosystem, are actively involved in the R&D of NK cell-based therapies for the treatment of various diseases including cancer. A large number of clinical trial applications for NK cell therapeutics have been submitted in recent times, reflecting a promising future for market growth.

Segmental Analysis

• On the basis of application, the oncology segment is expected to hold a prominent share on account of the increasing prevalence of cancer globally and increased demand for novel therapies for cancer treatment.
• On the basis of end users, the research center & institutes segment is set to observe the fastest growth rate on the back of increasing R&D efforts on drug and therapy development.
• Geographically, North America is expected to dominate the global NK cell therapeutics market due to the soaring investment by leading industry players in the development of NK cell-based therapies.

Competition Analysis: Significant market consolidation is expected in the near future

The global NK cell therapeutics market is at a nascent stage and is expected to flourish in the upcoming years. Players involved in the research & development of NK cell-based therapies are heavily investing in the sector with a keen focus on oncology treatment. Product innovations, launches, partnerships, mergers & acquisitions are the identified industry trends in the global NK cell therapeutics market. For instance,

• In August 2022, Zelluna Immunotherapy announced an investment from Takeda Ventures, Inc. (TVI), the strategic investing arm of Takeda. TVI investment joins Zelluna's latest financing round. The funds will enable the advancement of a lead TCR-NK product through manufacturing to Clinical Trial Application (CTA) / Investigational New Drug Application (IND) readiness and, continue the advancement of Zelluna's platform with additional programs reaching the preclinical stage.
• In January 2022, Takeda announced to acquire Adaptate Biotherapeutics to Develop Novel Gamma Delta (γδ) T Cell Engager Therapies Targeting Solid Tumors. Through the acquisition, Takeda would obtain Adaptate's antibody-based γδ T cell engager platform, including pre-clinical candidate and discovery pipeline programs. Adaptate's γδ T cell engagers are designed to specifically modulate γδ T cell-mediated immune responses at tumor sites while sparing damage to healthy cells.

Some of the leading players involved in the research & development, production, and marketing of NK cell therapeutics include Nkarta, Inc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Affimed GmbH, Zelluna Immunotherapy, Nektar Therapeutics, XNK Therapeutics AB, ONK Therapeutics, Catarman Bio, MiNK Therapeutics, Celularity Inc., Artiva Biotherapeutics and others.

RationalStat has segmented the Global NK Cell Therapeutics Market on the basis of application, end user, and region.

• By Application
o Cancer
o Gastrointestinal Diseases
o Immunoproliferative Disorders
o Others
• By End User
o Hospitals
o Research Centers and Institutes
o Others
• By Region
o North America
 US
 Canada
o Latin America
 Brazil
 Mexico
 Rest of Latin America
o Western Europe
 Germany
 UK
 France
 Spain
 Italy
 Benelux
 Nordic
 Rest of Western Europe
o Eastern Europe
 Russia
 Poland
 Rest of Eastern Europe
o Asia Pacific
 China
 Japan
 India
 South Korea
 Australia
 ASEAN (Indonesia, Vietnam, Malaysia, etc.)
 Rest of Asia Pacific
o Middle East & Africa
 GCC
 South Africa
 Turkey
 Rest of the Middle East & Africa

For more information about this report https://store.rationalstat.com/store/global-natural-killer-nk-cell-therapeutics-market-investment-growth-opportunity-analysis/

RationalStat LLC
Kimberly Shaw, Content and Press Manager
sales@rationalstat.com
Phone: +1 302 803 5429

RationalStat is an end-to-end US-based market intelligence and consulting company that provides comprehensive market research reports along with customized strategy and consulting studies. The company has sales offices in India, Mexico, and the US to support global and diversified businesses. The company has over 80 consultants and industry experts, developing more than 850 market research and industry reports for its report store annually.
RationalStat has strategic partnerships with leading data analytics and consumer research companies to cater to the client's needs. Additional services offered by the company include consumer research, country reports, risk reports, procurement intelligence, data analytics, and analytical dashboards.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Natural Killer (NK) Cell Therapeutics Market Analysis and Forecast, 2019-2028 - In-depth Market Report by RationalStat here

News-ID: 2738054 • Views: 368

More Releases from RationalStat LLC

Global Lactose-Free Butter Market Analysis and Forecast, 2019-2028 - In-depth Ma …
The report titled "Lactose-Free Butter Market" assesses the global and regional market based on category, type, application, distribution channel, and region. A comprehensive report provides a detailed historical and future market size with trend analysis. The report underlines the market share analysis, production capacities by leading players, overall consumption of lactose-free butter by region, competition overview, strategic imperatives, annual sales figures, growth avenues, production overview, future analysis, and competition assessment
Global At-Home Diagnosis Testing Market Analysis and Forecast, 2019-2028 - In-de …
The report titled "At-Home Diagnosis Testing Market" assesses the global market based on type, sample type, distribution channel, and region. A comprehensive report provides a detailed historical and future market size with a trend analysis. The market share analysis, production, competitive landscape, development plans, expansion opportunities, and competition analysis for the target companies evaluated in the global At-Home Diagnosis Testing market study are highlighted in the report. Market Overview and Dynamics:
The Automotive & Defense industry is expected to spur the market growth of the g …
The market report - Global 3D Printing Materials Market assesses the 3D printing materials market globally based on the basis of material type, form, and country/region. A comprehensive report provides a detailed historical and future market size with market trend analysis. RationalStat provides market share analysis, production capabilities, price points, a 3D printing market overview, the future of 3D printing in various end use industries, production and consumption by key
Shifting consumer preference toward green building materials is anticipated to h …
The report titled "Global Aerogel Insulation Market" assesses the aerogel insulation market globally based on the basis of product type, form, processing, application, and region. A comprehensive market report by RationalStat provides a detailed historical and future market size with a trend analysis. RationalStat provides market share analysis, production capabilities of the top companies, Covid-19 impact analysis, an overview of the competition, market strategies, and potential growth areas for the

All 5 Releases


More Releases for Therapeutics

Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity. Download the sample report @ https://www.pharmaproff.com/request-sample/1098 It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports. mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026. For inquiry or free sample pages email us at: sales@marketreportscompany.com The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”. Description:- The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from